Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis-Reference-Cited by-同舟云学术

Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis

Published:2018-06-04 Issue:4 Volume:45 Page:410-420
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathol Appl Neurobiol

Author:

Soponkanaporn S.¹²^ORCID,Deakin C. T.¹,Schutz P. W.¹³⁴,Marshall L. R.¹,Yasin S. A.¹,Johnson C. M.¹,Sag E.¹⁵,Tansley S. L.⁶,McHugh N. J.⁶,Wedderburn L. R.¹⁷⁸⁹^ORCID,Jacques T. S.¹⁰^ORCID

Affiliation:

1. Infection, Immunity and Inflammation Programme UCL Great Ormond Street Institute of Child Health London UK

2. Division of Rheumatology Department of Pediatrics Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

3. Division of Neuropathology Vancouver General Hospital Vancouver BC Canada

4. Department of Pathology University of British Columbia Vancouver BC Canada

5. Department of Pediatric Rheumatology Faculty of Medicine Hacettepe University Ankara Turkey

6. Department of Pharmacy and Pharmacology University of Bath Bath UK

7. Rheumatology Unit Great Ormond Street Hospital for Children London UK

8. NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London London UK

9. Arthritis Research UK Centre for Adolescent Rheumatology at UCL, UCLH and GOSH London UK

10. Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health London UK

Funder

Action Medical Research

Arthritis Research UK

National Institute for Health Research

Publisher

Wiley

Subject

Physiology (medical),Clinical Neurology,Neurology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nan.12498

Reference35 articles.

1. Type I interferon pathway in adult and juvenile dermatomyositis

2. Interferon-α/β-mediated innate immune mechanisms in dermatomyositis

3. Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease

4. Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling

5. Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage;Annals of the Rheumatic Diseases;2024-09-05

2. Clinicopathological features and treatment outcome of juvenile idiopathic inflammatory myopathies with anti-melanoma differentiation associated gene 5 antibodies: A case series study;Medicine;2024-08-30

3. Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice;Best Practice & Research Clinical Rheumatology;2024-08

4. Idiopathische inflammatorische Myopathien;Zeitschrift für Rheumatologie;2024-06-12

5. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies;Journal of Neuromuscular Diseases;2024-01-02